Inventor · disambiguated record
Kevin Daniel Freeman-Cook
Also filed as: FREEMAN-COOK KEVIN · FREEMAN-COOK KEVIN D · FREEMAN-COOK KEVIN DANIEL
15 granted patents·14 pending applications·233 citations·filing 2003–2024
93Inventor score
Top patents by PatentIndex Score
29 records- 0197US11014911B2CDK2 inhibitorsPFIZER·Filed 2020·Granted May 25, 2021·11 cites·4 claims
- 0295US11718603B2CDK2 inhibitorsPFIZER·Filed 2021·Granted Aug 8, 2023·3 cites·21 claims
- 0395US7928109B2Sulfonyl amide derivatives for the treatment of abnormal cell growthPFIZER·Filed 2008·Granted Apr 19, 2011·36 cites·4 claims
- 0493US11773082B2CDK2 inhibitorsPFIZER·Filed 2021·Granted Oct 3, 2023·2 cites·25 claims
- 0593US10233188B2CDK2/4/6 inhibitorsPFIZER·Filed 2017·Granted Mar 19, 2019·13 cites·2 claims
- 0693US8440822B2Sulfonyl amide derivatives for the treatment of abnormal cell growthLUZZIO MICHAEL JOSEPH·Filed 2012·Granted May 14, 2013·20 cites·38 claims
- 0793US8247411B2Sulfonyl amide derivatives for the treatment of abnormal cell growthLUZZIO MICHAEL JOSEPH·Filed 2011·Granted Aug 21, 2012·22 cites·17 claims
- 0892US6900201B2N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitorsPFIZER·Filed 2003·Granted May 31, 2005·65 cites·33 claims
- 0990US10450297B2Sulfonyl amide derivatives for the treatment of abnormal cell growthPFIZER·Filed 2018·Granted Oct 22, 2019·5 cites·14 claims
- 1090US2025214963A1Sulfonyl amide derivatives for the treatment of abnormal cell growthPFIZER·Filed 2024·Application pending·0 cites
- 1189US6916807B2Triaryl-oxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitorsPFIZER·Filed 2003·Granted Jul 12, 2005·39 cites·47 claims
- 1285US2024109862A1Sulfonyl amide derivatives for the treatment of abnormal cell growthPFIZER·Filed 2023·Application pending·0 cites
- 1381US2024294506A1Cdk2 inhibitorsPFIZER·Filed 2023·Application pending·0 cites
- 1480US8318762B2Pyrazolospiroketone acetyl-CoA carboxylase inhibitorsCORBETT JEFFREY W·Filed 2009·Granted Nov 27, 2012·8 cites·12 claims
- 1579US2022251066A1Sulfonyl amide derivatives for the treatment of abnormal cell growthPFIZER·Filed 2021·Application pending·0 cites
- 1675US7119201B2Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitorsPFIZER·Filed 2003·Granted Oct 10, 2006·9 cites·53 claims
- 1775US2022324872A1CDK2/4/6 InhibitorsPFIZER·Filed 2022·Application pending·0 cites
- 1872US2020002310A1Sulfonyl amide derivatives for the treatment of abnormal cell growthPFIZER·Filed 2019·Application pending·0 cites
- 1967US11396512B2CDK2/4/6 inhibitorsPFIZER·Filed 2020·Granted Jul 26, 2022·0 cites·12 claims
- 2067US10800783B2CDK2/4/6 inhibitorsPFIZER·Filed 2019·Granted Oct 13, 2020·0 cites·16 claims
- 2167US2015080368A1Sulfonyl amide derivatives for the treatment of abnormal cell growthVERASTEM INC·Filed 2014·Application pending·0 cites
- 2266US2024140947A1Compound for the treatment of cancerPFIZER·Filed 2023·Application pending·0 cites
- 2365US2017327485A1Sulfonyl amide derivatives for the treatment of abnormal cell growthPFIZER·Filed 2017·Application pending·0 cites
- 2463US2014100368A1Sulfonyl amide derivatives for the treatment of abnormal cell growthLUZZIO MICHAEL JOSEPH·Filed 2013·Application pending·0 cites
- 2563US2017001981A1Sulfonyl amide derivatives for the treatment of abnormal cell growthPFIZER·Filed 2016·Application pending·0 cites
- 2662US2016130250A1Sulfonyl amide derivatives for the treatment of abnormal cell growthPFIZER·Filed 2016·Application pending·0 cites
- 2752US11203594B2Anti-proliferative agents for treating PAHPFIZER·Filed 2020·Granted Dec 21, 2021·0 cites·30 claims
- 2847US2008051419A1Amine derivatives useful as anticancer agentsPFIZER·Filed 2007·Application pending·0 cites
- 2939US2011009443A1Pyrazolospiroketone Acetyl-Coa Carboxylase InhibitorsFREEMAN-COOK KEVIN DANIEL·Filed 2009·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kevin Daniel Freeman-Cook files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →